BTIG analyst Ryan Zimmerman maintains Organogenesis Hldgs (NASDAQ:ORGO) with a Buy and raises the price target from $4 to $6.
- Headlines
- BTIG Maintains Buy on Organogenesis Hldgs, Raises Price Target to $6
BTIG Maintains Buy on Organogenesis Hldgs, Raises Price Target to $6
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
08:42
It is reported that MediaTek has postponed the introduction of the 2nm Dimensity 9500 chip, which will use Taiwan Semiconductor's N3P process.
TSM+3.49%
08:40
Strategists: The downside potential for 10-year Japanese government bond yields is limited, and the market is paying attention to the Bank of Japan's monetary policy.
08:37
Galaxy Securities: The rise of AI Agents is reshaping the AI Industry Chain.